Valuation: Optiscan Imaging Limited

Market Cap 125M 87.78M 76.55M 70.65M 64.77M 123M 8.45B 842M 330M 4.13B 330M 322M 14.23B P/E 2024
-31.8x
P/E 2025 -14.5x
Enterprise Value 122M 85.63M 74.67M 68.91M 63.18M 120M 8.24B 821M 322M 4.03B 322M 314M 13.88B EV / Sales 2024
62.1x
EV / Sales 2025 23.8x
Free-Float
36.32%
Yield 2024 *
-
Yield 2025 -
1 week+3.33%
Current month+29.17%
1 month+24.00%
3 months+29.17%
6 months+72.22%
Current year+55.00%
1 week 0.15
Extreme 0.147
0.16
1 month 0.12
Extreme 0.12
0.16
Current year 0.08
Extreme 0.08
0.16
1 year 0.08
Extreme 0.079
0.16
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.29
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 2021-12-12
Director of Finance/CFO - 2025-03-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2021-02-09
Chairman - 2021-04-18
Director/Board Member - 2021-05-05
Date Insider Type Main position Quantity % Market Cap.
05-21Sell

Director

-3,000,000 0.2873%
01-14Free

Chairman

419,094 0.0401%
01-14Free

Chief Executive Officer

6,157,719 0.5897%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+3.33%+47.62%+76.14% 113M
-1.10%+5.01%-12.69%-21.09% 13.34B
-1.89%-13.40%+57.84%-2.40% 4.39B
+2.13%-6.60%+61.22%+100.90% 1.17B
+3.33%+3.17%-32.66%-60.63% 1.17B
+1.60%+3.85%-37.97%-46.34% 1.1B
+1.62%+3.58%-45.15% - 901M
-1.19%-12.23%+108.81%+109.54% 551M
-0.47%+11.64%+44.85% - 318M
+1.37%+3.82%-52.35%+231.87% 257M
Average +0.54%-0.09%+13.95%+48.50% 2.33B
Weighted average by Cap. -0.59%-2.06%+4.36%-7.56%

Financials

2024 2025
Net sales 2.99M 2.09M 1.82M 1.68M 1.54M 2.94M 201M 20.06M 7.87M 98.52M 7.85M 7.68M 339M 3.72M 2.61M 2.28M 2.1M 1.93M 3.66M 251M 25.02M 9.82M 123M 9.8M 9.58M 423M
Net income -6.06M -4.25M -3.7M -3.42M -3.13M -5.96M -409M -40.71M -15.98M -200M -15.94M -15.59M -688M -6.31M -4.42M -3.86M -3.56M -3.26M -6.21M -426M -42.4M -16.64M -208M -16.6M -16.24M -717M
Net Debt -11.01M -7.71M -6.73M -6.21M -5.69M -10.83M -742M -73.96M -29.03M -363M -28.97M -28.33M -1.25B -3.07M -2.15M -1.88M -1.73M -1.59M -3.02M -207M -20.63M -8.1M -101M -8.08M -7.9M -349M
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
26-07-15 A$0.1550 0.00% 153,558
26-07-14 A$0.1550 0.00% 99,611
26-07-13 A$0.1550 0.00% 743,716
26-07-10 A$0.1550 +3.33% 601,131
26-07-09 A$0.1500 -3.23% 197,390